Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Virios Therapeutics, Inc. (VIRI) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Virios Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1818844.
Total stock buying since 2020: $509,936.
Total stock sales since 2020: $466.
Total stock option exercises since 2020: $24,989.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 40,335 | $51,246 | 0 | $0 | 0 | $0 |
| 2022 | 44,683 | $225,808 | 1,800 | $466 | 0 | $0 |
| 2021 | 35,144 | $214,912 | 0 | $0 | 3,204 | $24,989 |
| 2020 | 1,500 | $17,970 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-08 | 40,335 | $51,246 | 0 | $0 | 0 | $0 |
| 2022-12 | 0 | $0 | 1,800 | $466 | 0 | $0 |
| 2022-05 | 23,691 | $105,307 | 0 | $0 | 0 | $0 |
| 2022-03 | 2,797 | $14,966 | 0 | $0 | 0 | $0 |
| 2022-01 | 18,195 | $105,535 | 0 | $0 | 0 | $0 |
| 2021-12 | 14,027 | $78,756 | 0 | $0 | 0 | $0 |
| 2021-07 | 942 | $5,950 | 0 | $0 | 0 | $0 |
| 2021-04 | 15,675 | $96,761 | 0 | $0 | 0 | $0 |
| 2021-01 | 4,500 | $33,445 | 0 | $0 | 3,204 | $24,989 |
| 2020-12 | 1,500 | $17,970 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-21 | Pridgen William | Buy | 15,335 | 1.30 | 19,996 |
| 2023-08-17 | Duncan Gregory Scott (CHIEF EXECUTIVE OFFICER) | Buy | 25,000 | 1.25 | 31,250 |
| 2022-12-08 | Whitley Richard James | Sale | 1,800 | .26 | 466 |
| 2022-05-23 | Duncan Gregory Scott (CHIEF EXECUTIVE OFFICER) | Buy | 7,500 | 4.52 | 33,900 |
| 2022-05-23 | Walsh Angela (SVP OF FINANCE) | Buy | 2,000 | 4.58 | 9,150 |
| 2022-05-18 | Pridgen William | Buy | 241 | 4.50 | 1,084 |
| 2022-05-18 | Whitley Richard James | Buy | 500 | 4.53 | 2,262 |
| 2022-05-17 | Pridgen William | Buy | 13,450 | 4.38 | 58,911 |
| 2022-03-29 | Pridgen William | Buy | 600 | 4.94 | 2,964 |
| 2022-03-23 | Pridgen William | Buy | 2,197 | 5.46 | 12,002 |
| 2022-01-27 | Pridgen William | Buy | 4,180 | 5.98 | 24,996 |
| 2022-01-07 | De La Rosa Abel | Buy | 4,000 | 5.90 | 23,584 |
| 2022-01-06 | Whitley Richard James | Buy | 1,800 | 5.72 | 10,296 |
| 2022-01-04 | Keefer David R | Buy | 5,000 | 5.79 | 28,975 |
| 2022-01-04 | Thomas John C | Buy | 1,000 | 5.65 | 5,650 |
| 2022-01-03 | Pridgen William | Buy | 2,215 | 5.43 | 12,034 |
| 2021-12-23 | Whitley Richard James | Buy | 200 | 5.72 | 1,145 |
| 2021-12-21 | Duncan Gregory Scott (CHIEF EXECUTIVE OFFICER) | Buy | 5,000 | 5.52 | 27,615 |
| 2021-12-21 | Pridgen William | Buy | 8,827 | 5.66 | 49,996 |
| 2021-07-07 | Pridgen William | Buy | 942 | 6.32 | 5,950 |
| 2021-04-05 | Duncan Gregory Scott (Chief Executive Officer) | Buy | 15,675 | 6.17 | 96,761 |
| 2021-01-29 | Pridgen William | Buy | 3,500 | 7.47 | 26,145 |
| 2021-01-28 | Pridgen William | Option Ex | 801 | 7.80 | 6,247 |
| 2021-01-28 | Walsh Angela (VP of Finance) | Buy | 1,000 | 7.30 | 7,300 |
| 2021-01-28 | Keefer David R | Option Ex | 1,602 | 7.80 | 12,495 |
| 2021-01-06 | Duncan Gregory Scott (Chief Executive Officer) | Option Ex | 801 | 7.80 | 6,247 |
| 2020-12-17 | Pridgen William | Buy | 1,500 | 11.98 | 17,970 |
Insider trading activities including stock purchases, stock sales, and option exercises of VIRI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Virios Therapeutics, Inc. (symbol VIRI, CIK number 1818844) see the Securities and Exchange Commission (SEC) website.